Latest Ratios: P/E Ratio 50.5x · EV/EBITDA 16.7x · ROE 2.4%. (2016–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.7B | $1.3B | $1.4B | — | — | — | — | — | — | — | — |
| Enterprise Value | $2.4B | $2.0B | $1.9B | — | — | — | — | — | — | — | — |
| P/E Ratio → | 50.52 | 38.85 | 32.43 | — | — | — | — | — | — | — | — |
| P/S Ratio | 8.48 | 6.55 | 7.38 | — | — | — | — | — | — | — | — |
| P/B Ratio | 1.26 | 0.97 | 0.98 | — | — | — | — | — | — | — | — |
| P/FCF | 15.10 | 11.67 | 10.62 | — | — | — | — | — | — | — | — |
| P/OCF | 14.05 | 10.86 | 10.38 | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 10.04 | 10.18 | — | — | — | — | — | — | — | — |
| EV / EBITDA | 16.66 | 13.98 | 13.93 | — | — | — | — | — | — | — | — |
| EV / EBIT | 36.40 | 30.09 | 29.78 | — | — | — | — | — | — | — | — |
| EV / FCF | — | 17.88 | 14.65 | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 87.9% | 87.9% | 87.6% | 89.3% | 90.0% | 89.8% | 90.1% | 89.4% | 41.1% | 38.3% | 42.8% |
| Operating Margin | 32.9% | 32.9% | 32.4% | 37.4% | 34.9% | 20.7% | 55.8% | 11.6% | 30.4% | 32.9% | 34.0% |
| Net Profit Margin | 16.8% | 16.8% | 22.8% | 12.7% | -4.4% | 233.0% | 22.2% | 2.7% | 19.1% | 16.9% | 20.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 2.4% | 2.4% | 2.9% | 1.6% | -0.5% | 24.7% | 2.2% | 0.1% | 1.3% | 1.1% | 0.8% |
| ROA | 1.6% | 1.6% | 2.1% | 1.1% | -0.4% | 15.0% | 1.1% | 0.1% | 4.2% | 5.7% | 22828.0% |
| ROIC | 2.5% | 2.5% | 2.4% | 2.6% | 2.2% | 1.1% | 2.4% | 0.3% | 1.6% | 1.7% | 1.1% |
| ROCE | 3.7% | 3.7% | 4.0% | 4.5% | 3.9% | 1.6% | 3.3% | 0.6% | — | — | — |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.54 | 0.54 | 0.40 | 0.38 | 0.40 | 0.33 | 0.68 | 0.83 | 0.00 | 0.00 | 0.00 |
| Debt / EBITDA | 5.08 | 5.08 | 4.13 | 3.87 | 4.45 | 4.48 | 5.67 | 16.75 | 0.05 | 0.05 | 0.02 |
| Net Debt / Equity | — | 0.52 | 0.37 | 0.24 | 0.39 | 0.31 | 0.65 | 0.79 | -0.02 | -0.03 | -0.04 |
| Net Debt / EBITDA | 4.85 | 4.85 | 3.83 | 2.49 | 4.35 | 4.21 | 5.40 | 15.94 | -0.37 | -0.56 | -0.90 |
| Debt / FCF | — | 6.21 | 4.03 | 2.88 | 5.38 | 4.40 | 12.73 | 20.34 | -1.02 | -3.56 | -2.95 |
| Interest Coverage | 2.01 | 2.01 | 3.01 | 2.04 | 2.61 | 1.03 | — | 0.35 | 1.96 | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5488.22 | 5488.22 | 0.18 | 0.47 | 0.13 | 0.21 | 2.73 | — | 1.19 | 1.28 | 1.47 |
| Quick Ratio | 5488.22 | 5488.22 | 0.18 | 0.47 | 0.13 | 0.21 | 2.73 | — | 1.19 | 1.28 | 1.47 |
| Cash Ratio | 3587.56 | 3587.56 | 0.07 | 0.37 | 0.02 | 0.06 | 0.13 | — | 0.04 | 0.05 | 0.07 |
| Asset Turnover | — | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 | 0.05 | 0.03 | 0.20 | 0.17 | 1128.62 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 5.3% | 6.9% | 5.9% | — | — | — | — | — | — | — | — |
| Payout Ratio | 268.1% | 268.1% | 190.7% | 276.7% | — | 115.7% | 208.1% | 1779.1% | 119.1% | 137.1% | 154.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.0% | 2.6% | 3.1% | — | — | — | — | — | — | — | — |
| FCF Yield | 6.6% | 8.6% | 9.4% | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.5% | 0.7% | 4.5% | — | — | — | — | — | — | — | — |
| Total Shareholder Yield | 5.8% | 7.5% | 10.4% | — | — | — | — | — | — | — | — |
| Shares Outstanding | — | $56M | $57M | $57M | $56M | $56M | $55M | $39M | $33M | $25M | $17M |
Tenant credit migration risk
Based on reported figures, SILA's P/FFO multiple of approximately 23.9x in 2026Q1 suggests a valuation discount relative to broader healthcare REIT benchmarks, likely stemming from the market's ongoing recalibration following the company's recent transition from a non-traded structure to a publicly listed entity on the NYSE.
The current valuation appears to incorporate a 'complexity discount' that may not fully account for the portfolio's high-quality outpatient focus. Investors should monitor whether this multiple expands as the company establishes a longer track record of public market performance and transparency.
According to historical data, SILA's AFFO payout ratio has fluctuated between 71% and 87% over the past several quarters, suggesting that the current dividend distribution remains well-supported by recurring cash flows generated from the company's triple-net lease portfolio.
The consistency of these payout levels implies a disciplined approach to capital allocation that prioritizes dividend stability. However, investors should remain cautious regarding potential volatility in AFFO if tenant rent coverage ratios face pressure from rising labor costs in the healthcare sector.
As reported in financial statements, SILA has achieved a debt-free status as of 2026Q1, representing a significant shift from the 0.54 debt-to-equity ratio observed in 2025Q4 and providing the REIT with substantial dry powder for future accretive acquisitions in the outpatient healthcare space.
This aggressive deleveraging event is highly atypical for the REIT sector and positions the company to navigate interest rate volatility with minimal refinancing risk. The absence of debt obligations suggests a fortress-like balance sheet that may allow for opportunistic growth when market conditions permit.
The standard P/E ratio is frequently misapplied to SILA, as it fails to account for the significant non-cash depreciation charges inherent in healthcare real estate, which artificially depress GAAP net income and obscure the company's true cash-generating capacity.
Investors should prioritize FFO and AFFO metrics, which adjust for these non-cash items and provide a more accurate reflection of the REIT's operational performance. Relying on P/E may lead to an erroneous conclusion that the stock is overvalued, when in fact the underlying cash flow remains robust.
Includes 30+ ratios · 10 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SILA stock.
Sila Realty Trust, Inc.'s current P/E ratio is 50.5x. The historical average is 35.6x. This places it at the 100th percentile of its historical range.
Sila Realty Trust, Inc.'s current EV/EBITDA is 16.7x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 14.0x.
Sila Realty Trust, Inc.'s return on equity (ROE) is 2.4%. The historical average is 3.7%.
Based on historical data, Sila Realty Trust, Inc. is trading at a P/E of 50.5x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Sila Realty Trust, Inc.'s current dividend yield is 5.28% with a payout ratio of 268.1%.
Sila Realty Trust, Inc. has 87.9% gross margin and 32.9% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Sila Realty Trust, Inc.'s Debt/EBITDA ratio is 5.1x, indicating high leverage. A ratio above 4x may signal elevated financial risk.